Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733667 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery
A NA study of Synechia, sponsored by ENTrigue Surgical.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 5
- Study locations
NCT01733667 is a NA study of Synechia that has completed, run by ENTrigue Surgical. The registered enrollment target is 60 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT01733667, a NA study of Synechia, has completed, sponsored by ENTrigue Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare the safety and effectiveness of MediENT to MeroPack after FESS.
Conditions Studied
Interventions
- DEVICE MediENT
- DEVICE MeroPack
Study Locations (5)
Texas
- ENT Associates of Texas - McKinney
- Ear, Nose & Throat Clinics of San Antonio - San Antonio
California
- Central California ENT Medical Group - Fresno
Colorado
- Colorado ENT & Allergy - Colorado Springs
Kentucky
- Advanced ENT and Allergy - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01733667
The ClinicalTrials.gov registry entry for NCT01733667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ENTrigue Surgical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Synechia appearing as the primary indexed condition, and to 2 interventions - of which MediENT is the first listed.
NCT01733667 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT01733667 about?
NCT01733667 is a clinical study titled "A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery". The purpose of this study is to compare the safety and effectiveness of MediENT to MeroPack after FESS.
What is the current status of trial NCT01733667?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-12. Estimated completion is 2013-02.
What conditions does trial NCT01733667 study?
This clinical trial studies the following conditions: Synechia.
What interventions are being tested in trial NCT01733667?
The interventions under investigation include: MediENT (DEVICE), MeroPack (DEVICE).
Who is sponsoring clinical trial NCT01733667?
This trial is sponsored by ENTrigue Surgical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01733667 being conducted?
This trial has 5 study locations across California, Colorado, Kentucky, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.